Crystagen

Moderate Research

Tripeptide bioregulator

Crystagen is a peptide bioregulator that has been studied in ophthalmology research for its effects on lens tissue gene expression. Published research has investigated its role in ocular tissue regulation. RaysunPeptide supplies Crystagen for qualified research and laboratory applications.

Mechanism of Action

Crystagen works through epigenetic regulation by influencing gene expression and protein synthesis in immune cells. It regulates the synthesis of heat-shock proteins, cytokines, and affects cell differentiation, proliferation, and apoptosis. The EDP peptide enhances spontaneous proliferative activity of normal lymphocytes while inhibiting proliferation of tumor cells (K-562 erythromyelosis). It activates B-cell immune system and thymic epithelial cells (VTEC2.H/S).

Key Benefits

1Normalizes immune function in 82% of patients
2Stimulates normal lymphocyte proliferation
3Inhibits tumor cell growth (antitumor activity)
4Doubles HSP gene expression (stress resistance)
5Reduces respiratory viral infections
6Activates B-cell immune system
7Normalizes IL-6 expression
8Effective after radiation/chemotherapy

Molecular Data

Molecular Weight
359 Da
Half-Life
Minutes (short peptide); effects persist via epigenetic changes
Chain Length
3 amino acids
Amino Acid Sequence
EDP

Dosing Protocols

GoalDoseFrequencyRoute
Standard protocol10-20 mgDaily for 10-20 daysOral capsules
Maintenance10 mg2-3 cycles yearlyOral capsules
Athletic support10-20 mgDaily during training cyclesOral capsules

Research Indications

Immune Support

Immune Dysfunctioneffective

Normalizes immunogram in elderly patients with impaired immunity.

Post-Infection Recoveryeffective

Restores immune function after infectious diseases.

Radiation/Chemo Recoveryeffective

Helps normalize immunity after radiation and chemotherapy exposure.

Stress Resistance

Athletic Immune Supporteffective

Increases stress resistance and reduces respiratory infections in athletes.

HSP Expressioneffective

Doubles expression of heat-shock protein gene HSPA1A.

Anti-Tumor

Tumor Cell Inhibitionmoderate

Inhibits proliferation of K-562 human erythromyelosis tumor cells.

Peptide Interactions

Vilon++ synergistic

Both have immunoprotecting properties; different mechanisms complement each other.

Thymalin++ synergistic

Crystagen (EDP) is derived from thymalin; complementary immune effects.

Epitalon++ synergistic

Often combined in comprehensive anti-aging Khavinson protocols.

Thymogen+ compatible

Related immune peptides; can be used together.

What to Expect

1
During cycle
Immune activation and gene expression modulation begins
2
Post-cycle
Effects persist due to epigenetic changes
3
Weeks
Measurable immune function improvements
4
Long-term
Cumulative benefits with periodic cycles

Side Effects & Safety

Common (Generally Mild)

  • •Generally well-tolerated
  • •Minimal side effects reported

Stop Signs (Seek Medical Attention)

  • ⚠Allergic reactions
  • ⚠Unusual immune symptoms

Contraindications

  • ✕Active autoimmune flares (consult physician)
  • ✕Known hypersensitivity
  • ✕Pregnancy or breastfeeding

Quality Checklist

Good Signs ✓

  • White powder or capsules
  • Clear solution if reconstituted
  • Proper packaging and labeling

Warning Signs !

  • Unknown source or purity

Bad Signs ✕

  • Discoloration
  • Unusual odor
  • Damaged packaging

References

The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity
• PMC/NCBI • 2021

EDP (crystagen) identified in thymalin; regulates gene expression, HSP synthesis, cytokines, and cell differentiation.

Crystagen in Elderly Patients with Impaired Immunity
• Advances in Gerontology • 2018

Crystagen normalized immunogram in 82% of patients vs 56% in control group.

Peptide Bioregulators in Athletes
• Bulletin of Experimental Biology and Medicine • 2019

Crystagen doubled HSP gene expression, normalized IL-6, and reduced respiratory infections in athletes.

EDP Peptide Effects on Lymphocyte Proliferation
• Cell Technologies in Biology and Medicine • 2017

EDP enhances normal lymphocyte proliferation while inhibiting K-562 tumor cell proliferation.

FAQs

Does Crystagen actually help athletes reduce respiratory infections?

Yes, research shows Crystagen doubled HSP gene expression in athletes and reduced respiratory infections in a study population. By enhancing heat-shock protein production and normalizing IL-6 expression, it strengthens immune resilience during heavy training stress when illness risk is elevated.

What percentage of elderly patients experience immune improvements with Crystagen?

Clinical research found Crystagen normalized immune function (immunogram) in 82% of elderly patients versus only 56% in the control group. This significant difference suggests it effectively reverses age-related immune decline, though results vary individually.

Is Crystagen safe to use if I have an active autoimmune condition?

Crystagen is an immune-stimulating peptide that may exacerbate active autoimmune flares since it enhances lymphocyte proliferation and immune activation. Medical consultation is essential before using, especially during autoimmune disease flares. It's better suited for those with immunodeficiency than autoimmunity.

Can Crystagen help protect immune function after chemotherapy?

Yes, research shows Crystagen effectiveness for normalizing immunity after chemotherapy and radiation exposure. As a thymus-derived immune bioregulator, it supports recovery of lymphocyte populations and immune surveillance that are suppressed by cancer treatments.

Crystagen

Dosing Summary

Dose
10-20 mg daily
Frequency
Once daily for 10-20 consecutive days
Cycle
10-20 days per cycle
Storage
Capsules: room temperature; Injectable lyophilized: 2-8°C; Reconstituted: 2-8°C refrigerated

Specifications

Purity≥98% (HPLC verified)
FormLyophilized powder
Packaging20mg
StorageStore at -20°C, protect from light
Catalog No.CRY20

Research Data

4
Studies
2021
Latest
0
Recent

Available Sizes

20mg$30